Grey or blue-grey whites of the eyes usually mean the sclera, the tough outer coat of the eyeball, has become thin enough for the darker tissue underneath to show through, or that pigment has been deposited in or on it by medications, metabolic byproducts, or melanin-producing cells. The sclera is normally white because its collagen fibers scatter light in all directions, but when those fibers thin out, lose their normal structure, or accumulate foreign pigment, the result is a grey, blue, or slate-colored tint that can range from barely noticeable to striking. Some causes are harmless and lifelong; others signal a condition worth investigating.
How the Sclera Stays White and What Changes That
The sclera is made almost entirely of collagen, the same structural protein found in skin, tendons, and bone. When those collagen fibers are densely packed and uniform, they reflect visible light without favoring any particular wavelength, so the surface looks white. Directly beneath the sclera sits the choroid, a layer packed with blood vessels and dark pigment cells. You do not normally see it because the sclera is opaque enough to block the view. Anything that thins the collagen, disorganizes its structure, or adds colored material to the tissue will let some of that underlying darkness peek through or introduce its own hue. The most common visual result is a blue-grey tint, because the physics of light scattering through a thinner, semi-translucent layer of collagen tends to shift visible wavelengths toward the blue end of the spectrum.
Connective Tissue Disorders
If your eye whites have looked blue-grey for as long as you can remember, one possibility is a genetic connective tissue condition. Osteogenesis imperfecta (sometimes called “brittle bone disease”) is the best-known example. The condition is caused by mutations in genes that encode type I collagen, and since that same collagen is the main building block of the sclera, people with osteogenesis imperfecta often have noticeably thinner scleral tissue. That thinning lets the dark choroid underneath show through, producing a characteristic blue or grey-blue sclera that eye doctors recognize on sight.1PubMed Central. Ocular characteristics and complications in patients with osteogenesis imperfecta: a systematic review
A related group of conditions, Ehlers-Danlos syndromes, also involves defective collagen and has been linked to various eye findings. These syndromes are genetically varied, with thirteen recognized subtypes, and ocular involvement can range from subtle to significant depending on the subtype.2PubMed Central. Ehlers-Danlos syndromes and their manifestations in the visual system Not everyone with these conditions will have grey sclera, but blue-tinged whites are recognized as a clinical clue.
The important point for anyone who has had blue or grey eye whites since childhood, especially alongside a history of fractures, unusually flexible joints, or stretchy skin, is that mentioning the scleral color to a doctor can sometimes help connect the dots to an underlying diagnosis.
Minocycline and Other Medications
If the grey-blue tint appeared after you started a medication, the most likely culprit is minocycline. This antibiotic, commonly prescribed long-term for acne and sometimes for rheumatoid arthritis, is well documented to cause blue-grey discoloration of the sclera, skin, nails, teeth, and other tissues over months to years of use.3PubMed Central. Minocycline-induced blue sclera and skin hyperpigmentation The pigment tends to concentrate in a band a few millimeters wide starting at the edge of the cornea, and it is usually more obvious in the area of the eye that is exposed between the lids, possibly because ultraviolet light accelerates the process.4PubMed. Minocycline-induced scleral pigmentation
The reassuring finding in reported cases is that minocycline-related scleral pigmentation does not appear to damage the eye’s structure or function. The discoloration can be cosmetically bothersome, though, and it may or may not fade after the drug is stopped. If you have been taking minocycline for months and notice a new grey-blue tint, it is worth bringing up with your prescriber so you can weigh the cosmetic trade-off against the medication’s benefits.
Melanocytic Pigmentation Conditions
Some people are born with extra melanin-producing cells (melanocytes) in and around the eye. Two closely related conditions fall into this category. Melanosis oculi involves excess melanocytes within the eye tissues alone, while the nevus of Ota adds a blue-grey skin patch on one side of the face, typically in the distribution of the trigeminal nerve. In the nevus of Ota, the sclera is involved in roughly two-thirds of cases, giving the white of the affected eye a distinctly slate-grey or blue-grey color.5PubMed Central. Unilateral open-angle glaucoma associated with the ipsilateral nevus of Ota
These conditions are usually harmless in themselves, but they do carry a small long-term risk. An estimated one in 400 affected individuals develops uveal melanoma, a cancer of the pigmented layer inside the eye. Those who do develop it face roughly double the usual risk of the cancer spreading compared with uveal melanoma patients without melanocytosis.6JAMA Ophthalmology. Association of Ocular and Oculodermal Melanocytosis With the Rate of Uveal Melanoma Metastasis For that reason, people with known melanosis oculi or nevus of Ota are usually advised to have regular dilated eye exams so that any change can be caught early.
It is also worth knowing that pigmented spots on the conjunctiva (the clear membrane over the sclera) can look like scleral grey patches to the untrained eye. These conjunctival lesions have a wide range of causes, from benign freckle-like nevi to primary acquired melanosis, which in some cases can progress to melanoma. A biopsy is sometimes recommended to distinguish harmless spots from potentially dangerous ones.7PubMed. Pigmented conjunctival and scleral lesions
Metabolic Causes
A rare but striking cause of grey-to-black scleral discoloration is alkaptonuria, a metabolic disorder in which the body cannot fully break down an amino acid called tyrosine. An intermediate product, homogentisic acid, builds up and gradually deposits dark pigment in cartilage, skin, and connective tissue throughout the body, a process called ochronosis.8PubMed Central. On the ocular findings in ochronosis: a systematic review of literature About half of people with alkaptonuria eventually develop enough pigment deposition for it to become visible.9JAMA Ophthalmology. Hereditary Alkaptonuria with Ochronosis
In the eye, ochronotic pigment typically shows up as brownish-grey or slate-colored patches on the sclera, often near where the muscles attach to the eyeball. The condition is inherited and extremely uncommon, so most people will never encounter it. But if grey scleral patches appear alongside darkened ear cartilage, joint stiffness, or urine that turns dark when left standing, alkaptonuria is worth considering.
Age-Related Scleral Changes
Aging itself can change the appearance of the sclera. One common finding in older adults is the scleral hyaline plaque, a small, slightly translucent or grey-tinged area where the collagen has undergone a degenerative change. A study of older adults in southeastern Brazil found these plaques in about 18 percent of participants, with the highest rates in people over 70, women, those with moderate to high nearsightedness, and those with degenerative arthritis.10PubMed Central. Prevalence and factors associated with scleral hyaline plaque: clinical study of older adults in southeastern Brazil The plaques are usually small, just a few millimeters across, and are not considered harmful. They tend to sit in the area of the sclera between the eyelids and may look like faint grey or yellowish-grey spots.
Beyond hyaline plaques, the sclera can simply yellow or grey slightly with age as lipid deposits accumulate and the collagen structure gradually changes. This is one reason that older adults sometimes notice their eye whites look duller than they once did, even without any specific disease.
High Myopia and Scleral Thinning
Severe nearsightedness can stretch the eyeball enough to thin the sclera, particularly at the back of the eye. While posterior scleral thinning is not usually visible from the front, people with very high myopia can sometimes develop areas where the sclera is noticeably thinner, and the dark choroid may show through as a blue-grey tint. Research has confirmed that eyes with posterior scleral bulging (staphyloma) have dramatically thinner tissue in that area compared with highly myopic eyes without bulging.11PubMed Central. The relationship between scleral staphyloma and choroidal thinning in highly myopic eyes: The Beijing Eye Study Most of this thinning is at the back and does not affect the front-facing sclera, but in extreme cases the entire sclera may be stretched enough to change its appearance.
Autoimmune Inflammation and Scleral Erosion
Chronic inflammatory diseases, especially rheumatoid arthritis, can silently erode the sclera over years. A condition called scleromalacia perforans gradually breaks down scleral tissue until it becomes paper-thin and develops a bluish hue. A case report describes a patient with long-standing rheumatoid arthritis whose sclera had thinned to only a fifth to a third of its normal thickness before the problem was discovered, and whose sclera appeared distinctly blue in both eyes.12PubMed Central. Case report: Scleromalacia caused by rheumatoid arthritis combined with high intraocular pressure, first discovered due to ocular trauma
Scleromalacia often causes few or no symptoms until the sclera becomes dangerously thin, making it a condition that can sneak up on people whose rheumatoid arthritis is not well controlled. Regular eye exams are especially valuable for anyone with a longstanding autoimmune condition that affects connective tissue.
Silver, Gold, and Other Environmental Deposits
Prolonged exposure to certain metals can deposit pigment in ocular tissues. The most dramatic example is argyrosis, caused by chronic ingestion or contact with silver compounds. People who take colloidal silver supplements for extended periods can develop a permanent grey-blue discoloration of the conjunctiva, cornea, and other eye structures as silver particles become trapped in the tissue’s membranes.13CRO Journal. Ocular Argyrosis Secondary to Long-term Ingestion of Self-Concocted Silver Colloidal Solution The discoloration is essentially permanent because the body has no efficient way to clear the deposited silver.
Gold therapy, once used more commonly for rheumatoid arthritis, can produce a similar phenomenon called chrysiasis, in which gold particles accumulate in the cornea and other ocular structures. It is rare, but documented.14PubMed. Deposition of gold in ocular structures, although known, is rare In both cases, the discoloration itself does not typically impair vision, but it serves as a visible reminder that the metal has accumulated throughout the body.
When to See a Doctor
A faint grey tint that has been present since birth and never changed is often just a normal variant, especially in infants and young children whose sclera has not yet reached its full adult thickness. Newborns and babies commonly have slightly blue-tinged sclera that whitens over the first year or two as the collagen matures. In adults, though, a new or worsening grey discoloration is worth an eye exam, particularly if any of the following apply:
- One eye only: Unilateral grey or blue patches raise the question of melanocytic conditions like nevus of Ota or melanosis oculi, which benefit from monitoring.
- Recent medication: Long-term use of minocycline or other tetracycline antibiotics is the most common drug-related cause and should be discussed with the prescriber.
- Joint problems or fractures: A history of easy fractures, loose joints, or autoimmune arthritis alongside blue sclera can point toward connective tissue or inflammatory conditions.
- Supplement use: Colloidal silver and other metal-containing supplements can cause irreversible discoloration that only gets worse with continued exposure.
An ophthalmologist can usually tell a great deal from a slit-lamp exam, which magnifies the eye enough to see whether the color change is within the sclera, on its surface in the conjunctiva, or in both. That distinction matters because conjunctival pigment and scleral pigment have different causes and different implications.
Scleral Tattooing and Cosmetic Risks
On the opposite end of the spectrum from people worried about grey sclera are people who intentionally change their scleral color through eyeball tattooing, a practice in which ink is injected under the conjunctiva to alter the appearance of the white of the eye. The procedure has grown in visibility through social media, but it carries serious risks. Documented complications include chronic pain, blurred vision, light sensitivity, granulomas (nodules of inflammatory tissue), ink migration into surrounding structures, and even globe penetration leading to retinal detachment or infection inside the eye.15PubMed Central. Case series: Two cases of eyeball tattoos with short-term complications The injected ink acts as a foreign body and can trigger ongoing inflammation or allergic reactions to the metallic components in the pigment.16Cornea. Scleral Tattooing Complications: Surgical Management of Granulomas in a Cosmetic Procedure
These procedures are performed by non-medical practitioners without surgical microscopes, and there is no standardized training or regulation in most places. For anyone considering the procedure to mask a grey or discolored sclera, the risk profile makes it a poor trade-off. An ophthalmologist can discuss safer cosmetic options, including tinted contact lenses designed to cover scleral discoloration, or simply monitor the underlying cause to make sure it is not progressing.